
Shaanxi Micot Pharmaceutical Technology Co., Ltd. engages in discovery, development and commercialization of bi-/multi-specific peptide drugs. The company engages in discovery, development and commercialization of bi-/multi-specific peptide drugs for the treatment of metabolic diseases as well as for cancer, cardiovascular, cerebrovascular, and neurological systemic diseases. The company was founded in founded in 2007 and is headquartered in Xi'an, China.